Thus, we can assume that high levels of pro-inflammatory IL-6, IP-10, and TNF α could promote pulmonary inflammation, followed by Th17 and neutrophil migration to the lungs, where they could secrete different cytokines and chemokines that provide inflammation and tissue damage through various effector mechanisms. The gene discussed is IL6; the disease is inflammation.